Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:138-142 (19 January), doi:10.1136/bmj.39399.656331.25 (published 4 December 2007)
Martin Underwood, professor of general practice1, Deborah Ashby, professor of medical statistics2, Pamela Cross, study clinician 1, Enid Hennessy, senior lecturer in medical statistics2, Louise Letley, senior nurse manager 3, Jeannett Martin, visiting fellow 4, Shahrul Mt-Isa, statistician 2, Suzanne Parsons, research fellow 1, Madge Vickers, research director 5, Ken Whyte, study manager1, on behalf of the TOIB study team
1 Centre for Health Sciences, Barts and The London, Queen Mary, University of London, London E1 2AT, 2 Wolfson Institute of Preventive Medicine, Barts and The London, Queen Mary, University of London, London EC1M 6BQ, 3 MRC General Practice Research Framework, London NW1 2ND, 4 Department of Primary and Social Care, London South Bank University, London SE1 6EN, 5 Clinical Trials Co-ordinating Centre, University of Hertfordshire, Hatfield, Herts AL10 9LB
Correspondence to: M Underwood m.underwood{at}qmul.ac.uk
Design Randomised controlled trial and patient preference study.
Setting 26 general practices.
Participants People aged
50 with knee pain: 282 in randomised trial and 303 in preference study.
Interventions Advice to use topical or oral ibuprofen.
Primary outcome measures WOMAC (Western Ontario and McMaster Universities) osteoarthritis index, major and minor adverse effects.
Results Changes in global WOMAC scores at 12 months were equivalent. In the randomised trial the difference (topical minus oral) was two points (95% confidence interval –2 to 6); in the preference study, it was one point (–4 to 6). There were no differences in major adverse effects in the trial or study. The only significant differences in secondary outcomes were in the randomised trial. The oral group had more respiratory adverse effects (17% v 7%,95% confidence interval for difference –17% to –2%), the change in serum creatinine was 3.7 mmol/l less favourable (0.9 µmol/l to 6.5 µmol/l); and more participants changed treatments because of adverse effects (16% v 1%, –16% to –5%). In the topical group more participants had chronic pain grade III or IV at three months, and more participants changed treatment because of ineffectiveness.
Conclusions Advice to use oral or topical preparations has an equivalent effect on knee pain over one year, and there are more minor side effects with oral NSAIDs. Topical NSAIDs may be a useful alternative to oral NSAIDs.
Trial registration ISRCTN 79353052.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?